N‑nitrosamines have become a major focus for regulators and manufacturers alike, especially after global recalls revealed how readily these potent impurities can form during production or storage. With agencies such as the FDA and EMA tightening expectations, understanding the risks — and how to manage them — is now essential.
This piece outlines the science, the regulatory pressures and the practical steps companies can take, including how Almac supports full lifecycle detection and control. To gain a clear, authoritative overview of this evolving issue, download the full article to learn more.